ACOD1 and hepatocellular carcinoma: In a study cohort consisting of 34 patients with HCC (table S2), we found that IRG1 staining signal was higher in αPD-1–resistant HCC patients (n = 12) than responsive patients (n = 22) (Fig. 5, E and F).